Plasmalogens inhibit APP processing by directly affecting γ -Secretase activity in alzheimer's disease

The Scientific World Journal

Volumn 2012, Issue , 2012, Pages

  Rothhaar, Tatjana L ^a   Grösgen, Sven ^a   Haupenthal, Viola J ^a   Burg, Verena K ^a   Hundsdörfer, Benjamin ^a   Mett, Janine ^a   Riemenschneider, Matthias ^a   Grimm, Heike S ^a   Hartmann, Tobias ^a,b   Grimm, Marcus O W ^a,b  

^a SAARLAND UNIVERSITY   (Germany)

^b SAARLAND UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SECRETASE; AMYLOID PRECURSOR PROTEIN; BETA SECRETASE; GAMMA SECRETASE; PLASMALOGEN; RNA; SECRETASE;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; AUTOPSY; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ANALYSIS; FEMALE; HUMAN; HUMAN TISSUE; LIPID ANALYSIS; MALE; BRAIN; CELL LINE; ENZYMOLOGY; GENETICS; METABOLISM; MIDDLE AGED; PHYSIOLOGY; PROTEIN PROCESSING;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; AMYLOID PRECURSOR PROTEIN SECRETASES; BRAIN; CELL LINE; FEMALE; HUMANS; MALE; MIDDLE AGED; PLASMALOGENS; PROTEIN PROCESSING, POST-TRANSLATIONAL; RNA;

EID: 84861091410     PISSN: None     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1100/2012/141240     Document Type: Article

References (76)

1. Horrocks L. A., Sharma M., Hawthorne J. N., Answell G. B., Plasmalogen and O-alkyl glycerophospholipids Phospholipids 1982 Amsterdam, The Netherlands Elsevier 51 93
2. Gross R. W., Identification of plasmalogen as the major phospholipid constituent of cardiac sarcoplasmic reticulum Biochemistry 1985 24 7 1662 1668 (Pubitemid 15089159)
3. Farooqui A. A., Horrocks L. A., Plasmalogens: workhorse lipids of membranes in normal and injured neurons and glia Neuroscientist 2001 7 3 232 245 (Pubitemid 32489117)
4. Zoeller R. A., Morand O. H., Raetz C. R., A possible role for plasmalogens in protecting animal cells against photosensitized killing Journal of Biological Chemistry 1988 263 23 11590 11596
5. Breckenridge W. C., Morgan I. G., Zanetta J. P., Vincendon G., Adult rat brain synaptic vesicles. II. Lipid composition Biochimica et Biophysica Acta 1973 320 3 681 686
6. Glaser P. E., Gross R. W., Plasmenylethanolamine facilitates rapid membrane fusion: a stopped-flow kinetic investigation correlating the propensity of a major plasma membrane constituent to adopt an HII phase with its ability to promote membrane fusion Biochemistry 1994 33 19 5805 5812 (Pubitemid 24184584)
7. Ford D. A., Hale C. C., Plasmalogen and anionic phospholipid dependence of the cardiac sarcolemmal sodium-calcium exchanger FEBS Letters 1996 394 1 99 102 (Pubitemid 26321212)
8. Duhm J., Engelmann B., Schonthier U. M., Streich S., Accelerated maximal velocity of the red blood cell Na+/K+ pump in hyperlipidemia is related to increase in 1-palmitoyl, 2-arachidonoyl-plasmalogen phosphatidylethanolamine Biochimica et Biophysica Acta 1993 1149 1 185 188 (Pubitemid 23186319)
9. Young C., Gean P. W., Chiou L. C., Shen Y. Z., Docosahexaenoic acid inhibits synaptic transmission and epileptiform activity in the rat hippocampus Synapse 2000 37 2 90 94 (Pubitemid 30447939)
10. Nagan N., Hajra A. K., Larkins L. K., Lazarow P., Purdue P. E., Rizzo W. B., Zoeller R. A., Isolation of a Chinese hamster fibroblast variant defective in dihydroxyacetonephosphate acyltransferase activity and plasmalogen biosynthesis: use of a novel two-step selection protocol Biochemical Journal 1998 332, part 1 273 279 (Pubitemid 28239345)
11. Mandel H., Sharf R., Berant M., Wanders R. J., Vreken P., Aviram M., Plasmalogen phospholipids are involved in HDL-mediated cholesterol efflux: insights from investigations with plasmalogen-deficient cells Biochemical and Biophysical Research Communications 1998 250 2 369 373 (Pubitemid 28463884)
12. Farooqui A. A., Horrocks L. A., Plasmalogens, phospholipase A2, and docosahexaenoic acid turnover in brain tissue Journal of Molecular Neuroscience 2001 16 2-3 263 272 (Pubitemid 32664787)
13. Farooqui A. A., Rosenberger T. A., Horrocks L. A., Yehuda S., Mostofsky D. I., Arachidonic acid, neurotrauma, and neurodegenerative diseases Handbook of Essential Fatty Acid Biology 1997 Totowa, NJ, USA Humana Press 277 296
14. Yang H. C., Farooqui A. A., Horrocks L. A., Plasmalogen-selective phospholipase A2 and its role in signal transduction Journal of Lipid Mediators and Cell Signalling 1996 14 13 9 13 (Pubitemid 26343331)
15. Ginsberg L., Rafique S., Xuereb J. H., Rapoport S. I., Gershfeld N. L., Disease and anatomic specificity of ethanolamine plasmalogen deficiency in Alzheimer's disease brain Brain Research 1995 698 1-2 223 226
16. Wells K., Farooqui A. A., Liss L., Horrocks L. A., Neural membrane phospholipids in Alzheimer disease Neurochemical Research 1995 20 11 1329 1333 (Pubitemid 26003436)
17. Guan Z., Wang Y., Cairns N. J., Lantos P. L., Dallner G., Sindelar P. J., Decrease and structural modifications of phosphatidylethanolamine plasmalogen in the brain with Alzheimer disease Journal of Neuropathology and Experimental Neurology 1999 58 7 740 747 (Pubitemid 29328503)
18. Demediuk P., Saunders R. D., Anderson D. K., Membrane lipid changes in laminectomized and traumatized cat spinal cord Proceedings of the National Academy of Sciences of the United States of America 1985 82 20 7071 7075 (Pubitemid 16209694)
19. Viani P., Zini I., Cervato G., Biagini G., Agnati L. F., Cestaro B., Effect of endothelin-1 induced ischemia on peroxidative damage and membrane properties in rat striatum synaptosomes Neurochemical Research 1995 20 6 689 695
20. Zhang J. P., Sun G. Y., Free fatty acids, neutral glycerides, and phosphoglycerides in transient focal cerebral ischemia Journal of Neurochemistry 1995 64 4 1688 1695
21. Schedin S., Sindelar P. J., Pentchev P., Brunk U., Dallner G., Peroxisomal impairment in Niemann-Pick type C disease Journal of Biological Chemistry 1997 272 10 6245 6251 (Pubitemid 27118096)
22. Yanagihara T., Cumings J. N., Alterations of phospholipids, particularly plasmalogens, in the demyelination of multiple sclerosis as compared with that of cerebral oedema Brain 1969 92 1 59 70
23. Farooqui A. A., Rapoport S. I., Horrocks L. A., Membrane phospholipid alterations in Alzheimer's disease: deficiency of ethanolamine plasmalogens Neurochemical Research 1997 22 4 523 527 (Pubitemid 27184719)
24. Han X., Holtzman D. M., McKeel D. W. Jr., Plasmalogen deficiency in early Alzheimer's disease subjects and in animal models: molecular characterization using electrospray ionization mass spectrometry Journal of Neurochemistry 2001 77 4 1168 1180 (Pubitemid 32467071)
25. Pettegrew J. W., Panchalingam K., Hamilton R. L., Mcclure R. J., Brain membrane phospholipid alterations in Alzheimer's disease Neurochemical Research 2001 26 7 771 782 (Pubitemid 32845968)
26. Masters C. L., Simms G., Weinman N. A., Amyloid plaque core protein in Alzheimer disease and Down syndrome Proceedings of the National Academy of Sciences of the United States of America 1985 82 12 4245 4249 (Pubitemid 15053619)
27. Selkoe D. J., Cell biology of protein misfolding: the examples of Alzheimer's and Parkinson's diseases Nature Cell Biology 2004 6 11 1054 1061 (Pubitemid 39468006)
28. Haass C., Take fiveBACE and the -secretase quartet conduct Alzheimer's amyloid -peptide generation EMBO Journal 2004 23 3 483 488 (Pubitemid 38282380)
29. Sinha S., Anderson J. P., Barbour R., Basi G. S., Caccaveffo R., Davis D., Doan M., Dovey H. F., Frigon N., Hong J., Jacobson-Croak K., Jewett N., Keim P., Knops J., Lieberburg I., Power M., Tan H., Tatsuno G., Tung J., Schenk D., Seubert P., Suomensaari S. M., Wang S., Walker D., Zhao J., McConlogue L., John V., Purification and cloning of amyloid precursor protein -secretase from human brain Nature 1999 402 6761 537 540
30. Steiner H., Fluhrer R., Haass C., Intramembrane proteolysis by -secretase Journal of Biological Chemistry 2008 283 44 29627 29631
31. Wakabayashi T., De Strooper B., Presenilins: members of the -secretase quartets, but part-time soloists too Physiology 2008 23 4 194 204
32. Buxbaum J. D., Liu K. N., Luo Y., Slack J. L., Stocking K. L., Peschon J. J., Johnson R. S., Castner B. J., Cerretti D. P., Black R. A., Evidence that tumor necrosis factor converting enzyme is involved in regulated -secretase cleavage of the Alzheimer amyloid protein precursor Journal of Biological Chemistry 1998 273 43 27765 27767 (Pubitemid 28496060)
33. Lammich S., Kojro E., Postina R., Gilbert S., Pfeiffer R., Jasionowski M., Haass C., Fahrenholz F., Constitutive and regulated -secretase cleavage of Alzheimer's amyloid precursor protein by a disintegrin metalloprotease Proceedings of the National Academy of Sciences of the United States of America 1999 96 7 3922 3927 (Pubitemid 29169012)
34. Koike H., Tomioka S., Sorimachi H., Saido T. C., Maruyama K., Okuyama A., Fujisawa-Sehara A., Ohno S., Suzuki K., Ishiura S., Membrane-anchored metalloprotease MDC9 has an -secretase activity responsible for processing the amyloid precursor protein Biochemical Journal 1999 343, part 2 371 375 (Pubitemid 29511770)
35. Allinson T. M., Parkin E. T., Turner A. J., Hooper N. M., ADAMs family members as amyloid precursor protein -secretases Journal of Neuroscience Research 2003 74 3 342 352 (Pubitemid 37362810)
36. Braak H., Braak E., Neuropathological stageing of Alzheimer-related changes Acta Neuropathologica 1991 82 4 239 259
37. Smith P. K., Krohn R. I., Hermanson G. T., Measurement of protein using bicinchoninic acid Analytical Biochemistry 1985 150 1 76 85 (Pubitemid 16258399)
38. Livak K. J., Schmittgen T. D., Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method Methods 2001 25 4 402 408 (Pubitemid 34164012)
39. Grimm M. O., Kuchenbecker J., Rothhaar T. L., Plasmalogen synthesis is regulated via alkyl-dihydroxyacetonephosphate-synthase by amyloid precursor protein processing and is affected in Alzheimer's disease Journal of Neurochemistry 2011 116 5 916 925
40. Grimm M. O., Grsgen S., Riemenschneider M., Tanila H., Grimm H. S., Hartmann T., From brain to food: analysis of phosphatidylcholins, lyso-phosphatidylcholins and phosphatidylcholin-plasmalogens derivates in Alzheimer's disease human post mortem brains and mice model via mass spectrometry Journal of Chromatography A 2011 1218 42 7713 7722
41. Grimm M. O., Grimm H. S., Tomic I., Beyreuther K., Hartmann T., Bergmann C., Independent inhibition of Alzheimer disease -and -secretase cleavage by lowered cholesterol levels Journal of Biological Chemistry 2008 283 17 11302 11311
42. Grimm M. O., Kuchenbecker J., Grsgen S., Burg V. K., Hundsdorfer B., Rothhaar T. L., Friess P., De Wilde M. C., Broersen L. M., Penke B., Peter M., Vgh L., Grimm H. S., Hartmann T., Docosahexaenoic acid reduces amyloid production via multiple pleiotropic mechanisms Journal of Biological Chemistry 2011 286 16 14028 14039
43. Allinson T. M., Parkin E. T., Condon T. P., Schwager S. L. U., Sturrock E. D., Turner A. J., Hooper N. M., The role of ADAM10 and ADAM17 in the ectodomain shedding of angiotensin converting enzyme and the amyloid precursor protein European Journal of Biochemistry 2004 271 12 2539 2547 (Pubitemid 38813584)
44. Miyazawa T., Kanno S., Eitsuka T., Nakagawa K., Yanagita Y., Knapp, H. R., Huang Y. S., Plasmalogen: a short review ans newly-discovered functions Dietary Fats and Risk of Chronic Disease 2006 AOCS Publishing 196 202
45. Spector A. A., Yorek M. A., Membrane lipid composition and cellular function Journal of Lipid Research 1985 26 9 1015 1035 (Pubitemid 16258287)
46. Prasad M. R., Lovell M. A., Yatin M., Dhillon H., Markesbery W. R., Regional membrane phospholipid alterations in Alzheimer's disease Neurochemical Research 1998 23 1 81 88 (Pubitemid 28145695)
47. Goodenowe D. B., Cook L. L., Liu J., Lu Y., Jayasinghe D. A., Ahiahonu P. W. K., Heath D., Yamazaki Y., Flax J., Krenitsky K. F., Sparks D. L., Lerner A., Friedland R. P., Kudo T., Kamino K., Morihara T., Takeda M., Wood P. L., Peripheral ethanolamine plasmalogen deficiency: a logical causative factor in Alzheimer's disease and dementia Journal of Lipid Research 2007 48 11 2485 2498 (Pubitemid 350058760)
48. Wood P. L., Mankidy R., Ritchie S., Heath D., Wood J. A., Flax J., Goodenowe D. B., Circulating plasmalogen levels and Alzheimer disease assessment scale-cognitive scores in Alzheimer patients Journal of Psychiatry and Neuroscience 2010 35 1 59 62
49. Fabelo N., Martin V., Santpere G., Severe alterations in lipid composition of frontal cortex lipid rafts from Parkinson's disease and incidental Parkinson's disease Molecular Medicine 2011 17 9-10 1107 1118
50. Tamai Y., Kojima H., Ikuta F., Kumanishi T., Alterations in the composition of brain lipids in patients with Creutzfeldt-Jakob disease Journal of the Neurological Sciences 1978 35 1 59 76 (Pubitemid 8251561)
51. Federico A., Annunziata P., Malentacchi G., Neurochemical changes in Creutzfeldt-Jakob disease Journal of Neurology 1980 223 2 135 146 (Pubitemid 10112976)
52. Hein L. K., Duplock S., Hopwood J. J., Fuller M., Lipid composition of microdomains is altered in a cell model of Gaucher disease Journal of Lipid Research 2008 49 8 1725 1734
53. Hozumi I., Nishizawa M., Ariga T., Miyatake T., Biochemical and clinical analysis of accumulated glycolipids in symptomatic heterozygotes of angiokeratoma corporis diffusum (Fabry's disease) in comparison with hemizygotes Journal of Lipid Research 1990 31 2 335 340 (Pubitemid 20089048)
54. Maalouf K., Jia J., Rizk S., Brogden G., Keiser M., Das A., Naim H. Y., A modified lipid composition in Fabry disease leads to an intracellular block of the detergent-resistant membrane-associated dipeptidyl peptidase IV Journal of Inherited Metabolic Disease 2010 33 4 445 449
55. Fassbender K., Simons M., Bergmann C., Stroick M., Ltjohann D., Keller P., Runz H., Khl S., Von Bergman T., Bertsch K., Hennerici M., Beyreuther K., Hartmann T., Simvastatin strongly reduces levels of Alzheimer's disease -amyloid peptides A 42 and A 40 in vitro and in vivo Proceedings of the National Academy of Sciences of the United States of America 2001 98 10 5856 5861 (Pubitemid 32435732)
56. Zha Q., Ruan Y., Hartmann T., Beyreuther K., Zhang D., GM1 ganglioside regulates the proteolysis of amyloid precursor protein Molecular Psychiatry 2004 9 10 946 952 (Pubitemid 39381958)
57. Wolozin B., Cholesterol and the biology of Alzheimer's disease Neuron 2004 41 1 7 10 (Pubitemid 38068431)
58. Grimm M. O., Grimm H. S., Patzold A. J., Zinser E. G., Halonen R., Duering M., Tschpe J.-A., De Strooper B., Mller U., Shen J., Hartmann T., Regulation of cholesterol and sphingomyelin metabolism by amyloid- and presenilin Nature Cell Biology 2005 7 11 1118 1123
59. Furukawa K., Sopher B. L., Rydel R. E., Begley J. G., Pham D. G., Martin G. M., Fox M., Mattson M. P., Increased activity-regulating and neuroprotective efficacy of -secretase-derived secreted amyloid precursor protein conferred by a C-terminal heparin-binding domain Journal of Neurochemistry 1996 67 5 1882 1896 (Pubitemid 26349661)
60. Meziane H., Dodart J. C., Mathis C., Little S., Clemens J., Paul S. M., Ungerer A., Memory-enhancing effects of secreted forms of the -amyloid precursor protein in normal and amnestic mice Proceedings of the National Academy of Sciences of the United States of America 1998 95 21 12683 12688 (Pubitemid 28483825)
61. Mattson M. P., Guo Z. H., Geiger J. D., Secreted form of amyloid precursor protein enhances basal glucose and glutamate transport and protects against oxidative impairment of glucose and glutamate transport in synaptosomes by a cyclic GMP-mediated mechanism Journal of Neurochemistry 1999 73 2 532 537 (Pubitemid 29339825)
62. von Rotz R. C., Kohli B. M., Bosset J., Meier M., Suzuki T., Nitsch R. M., Konietzko U., The APP intracellular domain forms nuclear multiprotein complexes and regulates the transcription of its own precursor Journal of Cell Science 2004 117 19 4435 4448 (Pubitemid 39360070)
63. Grimm M. O., Grsgen S., Rothhaar T. L., Burg V. K., Hundsdrfer B., Haupenthal V. J., Friess P., Mller U., Fassbender K., Riemenschneider M., Grimm H. S., Hartmann T., Intracellular APP domain regulates serine-palmitoyl-CoA transferase expression and is affected in alzheimer's disease International Journal of Alzheimer's Disease 2011
64. Blacker M., Noe M. C., Carty T. J., Goodyer C. G., LeBlanc A. C., Effect of tumor necrosis factor- converting enzyme (TACE) and metalloprotease inhibitor on amyloid precursor protein metabolism in human neurons Journal of Neurochemistry 2002 83 6 1349 1357 (Pubitemid 35477474)
65. Karkkainen I., Rybnikova E., Pelto-Huikko M., Huovila A. P., Metalloprotease-disintegrin (ADAM) genes are widely and differentially expressed in the adult CNS Molecular and Cellular Neurosciences 2000 15 6 547 560 (Pubitemid 30436928)
66. Llano E., Adam G., Pendas A. M., Quesada V., Snchez L. M., Santamara I., Noselli S., Lpez-Otn C., De Oviedo U., Structural and enzymatic characterization of Drosophila Dm2-MMP, a membrane-bound matrix metalloproteinase with tissue-specific expression Journal of Biological Chemistry 2002 277 26 23321 23329 (Pubitemid 34952162)
67. Lin J., Yan X., Markus A., Redies C., Rolfs A., Luo J., Expression of seven members of the ADAM family in developing chicken spinal cord Developmental Dynamics 2010 239 4 1246 1254
68. Han X., Multi-dimensional mass spectrometry-based shotgun lipidomics and the altered lipids at the mild cognitive impairment stage of Alzheimer's disease Biochimica et Biophysica Acta 2010 1801 8 774 783
69. Subbarao K. V., Richardson J. S., Ang L. S., Autopsy samples of Alzheimer's cortex show increased peroxidation in vitro Journal of Neurochemistry 1990 55 1 342 345
70. Mark R. J., Pang Z., Geddes J. W., Uchida K., Mattson M. P., Amyloid -peptide impairs glucose transport in hippocampal and cortical neurons: involvement of membrane lipid peroxidation Journal of Neuroscience 1997 17 3 1046 1054 (Pubitemid 27043963)
71. Markesbery W. R., Oxidative stress hypothesis in Alzheimer's disease Free Radical Biology and Medicine 1997 23 1 134 147 (Pubitemid 27217017)
72. Yatin S. M., Varadarajan S., Link C.D., Butterfield D. A., In vitro and in vivo oxidative stress associated with Alzheimer's amyloid beta-peptide (142) Neurobiol Aging 1999 20 3 325 330 (Pubitemid 29525418)
73. Butterfield D. A., Lauderback C. M., Lipid peroxidation and protein oxidation in Alzheimer's disease brain: potential causes and consequences involving amyloid -peptide-associated free radical oxidative stress Free Radical Biology and Medicine 2002 32 11 1050 1060 (Pubitemid 34603342)
74. Mohmmad Abdul H., Wenk G. L., Gramling M., Hauss-Wegrzyniak B., Butterfield D. A., APP and PS-1 mutations induce brain oxidative stress independent of dietary cholesterol: implications for Alzheimer's disease Neuroscience Letters 2004 368 2 148 150 (Pubitemid 39194861)
75. Sanchez-Mejia R. O., Newman J. W., Toh S., Yu G. Q., Zhou Y., Halabisky B., Cissé M., Scearce-Levie K., Cheng I. H., Gan L., Palop J. J., Bonventre J. V., Mucke L., Phospholipase A2 reduction ameliorates cognitive deficits in a mouse model of Alzheimer's disease Nature Neuroscience 2008 11 11 1311 1318
76. Sanchez-Mejia R. O., Mucke L., Phospholipase A2 and arachidonic acid in Alzheimer's disease Biochimica et Biophysica Acta 2010 1801 8 784 790